Nuevos avances en la investigación sobre el envejecimiento

Introduction to Aging and Biology

Welcome and Context

• Cristina Sánchez, Dean of Research at the Complutense University of Madrid, welcomes attendees to a session on biology in the media.

• The session aims to explore impactful biological news, focusing today on "white noise" related to aging and health.

Understanding White Noise in Health News

• White noise refers to constant exposure to news about degenerative diseases like Alzheimer's and cancer, alongside healthy lifestyle habits.

• The World Health Organization estimates that by 2050, the percentage of people over 60 will double from 12% to 22%, posing significant challenges for healthcare systems globally.

The Role of Biology in Aging

Biological Contributions

• The discussion centers on how biology can help manage aging-related issues by understanding processes during aging.

• Manuel Serrano, a leading scientist in molecular oncology, is introduced as a speaker who has made significant contributions to cancer research.

Manuel Serrano's Background

• Serrano completed his PhD in molecular biology at the Autonomous University of Madrid and has led research groups since returning from postdoctoral work in the U.S.

• His notable achievements include discovering an inhibitor related to tumor suppression and demonstrating cellular reprogramming.

Advancements in Aging Research

Focus on Senescence

• Serrano's current research aims at applying knowledge from oncology to address degenerative diseases and aging through cellular reprogramming techniques.

Opening Remarks by Manuel Serrano

• Serrano expresses gratitude for the opportunity to speak internationally about advancements in aging research.

Changing Perspectives on Disease

Shift in Medical Mindset

• There is a changing mindset among scientists regarding how diseases are perceived; traditionally viewed as isolated conditions rather than interconnected issues.

Age as a Primary Risk Factor

• Many medical professionals focus narrowly on specific diseases without recognizing age as a common risk factor across various conditions.

Importance of Age Consideration

• While genetics and lifestyle factors contribute significantly (10%-20%), age accounts for approximately 80% of disease risk. This critical insight often gets overlooked.

Conclusion: Implications for Healthcare

Understanding Aging's Impact on Health

Understanding Aging and Its Implications

The Challenge of Aging and Disease

• Due to age, individuals face a high risk of developing multiple diseases. Current medical advancements have improved disease management but have not significantly increased longevity.

• The typical scenario today involves patients suffering from multiple ailments, complicating treatment as the root cause—aging—is often overlooked.

Perspectives on Anti-Aging Medicine

• Notable institutions like MIT publish insights on revolutionary advancements every decade, highlighting anti-aging medicine as a significant focus for future developments.

• Despite skepticism surrounding anti-aging treatments, it is essential to recognize that any medical intervention aimed at prolonging life can be considered anti-aging.

Understanding Cellular Aging

• All forms of medical care can be viewed as anti-aging efforts since they aim to maintain survival; however, the scientific focus should shift towards addressing aging itself rather than just individual diseases.

• Physical signs of aging, such as wrinkles, reflect internal biological changes; both external and internal aging processes occur simultaneously.

Mechanisms of Cellular Damage and Repair

• Various approaches are being explored to combat aging, particularly therapies targeting damaged cells. Clinical trials are already underway for these promising treatments.

• Cells constantly face damage from various sources (e.g., lifestyle choices and infections), leading to mechanisms that attempt repair or elimination when damage exceeds repair capacity.

Apoptosis vs. Senescence in Cell Response

• When cells incur damage beyond their repair capabilities, they may undergo apoptosis (self-destruction) or senescence (a state where they cease to divide but remain metabolically active).

• Senescent cells signal other immune cells (like macrophages and NK cells) to assist in tissue repair rather than self-destructing immediately.

The Role of Senescence in Tissue Regeneration

• Senescence serves as a more common response than apoptosis; it alerts the body about cellular damage while promoting healing through secretions that attract repair cells.

• Damaged senescent cells secrete factors that modify their environment favorably for tissue regeneration by stimulating neighboring healthy cells.

Decision-Making in Cellular Responses

• Cells exhibit flexibility by activating both apoptotic and senescent pathways simultaneously based on the context of damage encountered.

Cellular Senescence and Its Implications

Understanding Cellular Senescence

• Cellular senescence is a response mechanism that alerts the body to damage, leading to the activation of macrophages for elimination. When senescent cells undergo apoptosis, they are primed but not executed, making them prone to activate cell death.

• Senescent cells can be pharmacologically induced to die even if they haven't naturally died. They inhibit their own proliferation while promoting neighboring cell growth through secreted mitogenic factors.

• To prevent self-proliferation, senescent cells activate inhibitors like p16INK4a and p21, which serve as markers in detecting cellular senescence.

Characteristics and Pathological Associations

• Senescent cells induce proliferation in adjacent healthy cells while blocking their own growth. This process is often accompanied by an expansion of lysosomal compartments.

• Recent studies have shown a high prevalence of senescent cells across various pathologies such as Alzheimer's disease and Parkinson's disease, indicating a significant role in these conditions.

• Conditions like pulmonary fibrosis, obesity-related inflammation, atherosclerosis, cardiac fibrosis, sudden cardiac failure, and diabetes are linked with massive accumulations of senescent cells attempting tissue repair without success.

Mechanisms Behind Tissue Repair Failure

• The accumulation of senescent cells occurs when tissue regeneration capacity is exhausted due to complex immune responses or ineffective neighboring cell activation.

• The inability of the immune system to function optimally may hinder the repair processes initiated by senescent cells. This leads to pathological outcomes where beneficial processes become harmful over time.

In Vitro Studies on Senescence

• In vitro studies demonstrate that damaged non-senescent cells can be induced into a senescent state using cytotoxic agents like chemotherapy drugs (e.g., cisplatin).

• While non-proliferative, these damaged cells increase in size without undergoing division—resulting in giant cell formation observable under specific laboratory conditions.

Implications for Aging and Treatment Strategies

• Damage triggers a repair response involving highly secretive inflammatory factors from damaged tissues. Repeated damage or aging impairs this repair efficiency leading to chronic issues.

• Accumulation rates differ between young (one week lifespan for senescent cells post-damage) and aged organisms (up to one month), contributing significantly to tissue dysfunction over time.

Understanding Cellular Senescence and Aging

The Role of Cellular Damage in Senescence

• Cellular senescence is an integrative response to various types of damage experienced throughout life, such as telomere shortening, which activates senescence when critically short.

• Stochastic errors during DNA replication and mitosis contribute to cellular damage; when these damages are irreparable, they lead to senescence.

• Defects in autophagy and mitochondrial function also result in cellular senescence, indicating that multiple pathways converge on this phenomenon.

Distinguishing Between Aging and Age-Related Diseases

• There are two perspectives: addressing age-related diseases versus the broader concept of aging itself. Most researchers focus on the former.

• Anti-aging therapies often target diseases associated with aging rather than maintaining perpetual youth; understanding the causes of these diseases allows for more realistic treatment approaches.

Chronic and Focalized Damage Leading to Disease

• Many age-related diseases stem from chronic, localized damage (e.g., hypertension causing aortic damage), leading to irreversible conditions like atherosclerosis.

• Similar mechanisms apply to organs like kidneys, where chronic exposure to stressors results in fibrosis and renal failure.

Conceptualizing Accelerated Aging through Disease

• Degenerative diseases can be viewed as forms of accelerated aging due to high levels of senescent cells contributing significantly (30%-50%) to tissue pathology.

• In healthy elderly individuals without disease, there is a diffuse accumulation of cellular damage over time rather than focalized injury.

Accumulation of Senescent Cells in Healthy Aging

• In older adults, only about 5%-10% of cells may be senescent across various tissues (e.g., liver, kidney), indicating that not all cells exhibit signs of senescence.

• The presence of these senescent cells leads to systemic inflammation due to cytokine production (e.g., interleukin 6), contributing further to the aging process.

Challenges in Targeting Aging for Therapeutics

• Aging is not currently a practical target for major pharmaceutical companies due to difficulties conducting clinical trials on healthy elderly populations.

• Research is shifting towards targeting senescent cells directly or exploring nutraceutical approaches that bypass traditional drug regulations.

Experimental Approaches in Understanding Senescence

Understanding Pulmonary Fibrosis and Cellular Senescence

The Nature of Pulmonary Fibrosis

• Pulmonary fibrosis is a progressive disease with limited treatment options, often leading to a life expectancy of about three years, similar to pancreatic cancer.

• Factors contributing to lung damage include environmental exposure (dust, bacteria, viruses), genetic predispositions, and aging. This leads to primary cellular damage in alveolar cells.

Secondary Senescence and Its Implications

• Young individuals can recover from significant damage (e.g., smoking), but older individuals may reach a point where repair mechanisms fail due to accumulated cellular senescence.

• If the initial repair fails, it triggers an alarm response that induces secondary senescence in neighboring cells, perpetuating the cycle of damage.

Mechanism of Disease Progression

• Continuous failure in cell repair leads to recruitment of more cells into a state of senescence, creating a feedback loop that exacerbates the condition.

• The progression mechanism explains why pulmonary fibrosis starts focal but expands significantly over time as more cells become senescent.

Histological Evidence and Markers

• Histological images reveal markers like p16 for identifying senescent alveolar cells in human pulmonary fibrosis cases; these cells appear rare and deformed.

• Other markers such as T21 are used for fibroblasts while p16 is specific for epithelial cell senescence.

Impact on Lung Functionality

• Fibrosis severely impairs lung functionality by affecting its ability to expand and contract harmoniously, leading to mechanical stress within the lungs.

Experimental Insights on Cellular Behavior

• Experiments involved irradiating human lung fibroblasts to induce senescence before injecting them into mice models without immune rejection concerns.

• After 21 days post-injection, both types of fibroblasts were found capable of colonizing the lungs successfully.

Observations Post Injection

Understanding Senescent Cells and Their Role in Disease

The Impact of Senescent Cells on Tissue Function

• Senescent cells produce excessive fibrosis, leading to a buildup of collagen that disrupts normal tissue function, impairing contraction and expansion.

• The progression of disease can be measured by assessing total collagen levels in the lungs, particularly through modified amino acids like hydroxyproline, which is characteristic of collagen.

• In experiments with mice injected with senescent cells, there was a significant increase in total collagen compared to controls, indicating a transition from human to mouse fibroblasts.

• Initial detection shows p21 protein expression in injected fibroblasts; however, over time, human cells diminish while mouse cells proliferate significantly.

• This model illustrates how non-proliferating senescent human cells can induce progressive disease through their interaction with mouse fibroblasts.

Therapeutic Approaches Targeting Senescence

• Current therapies aim to eliminate senescent cells due to their detrimental effects; however, some degree of senescence is necessary for tissue repair processes.

• The concept of "assisted suicide" for chronic senescence suggests using drugs (senolytics) to selectively target and eliminate harmful senescent cells without disrupting beneficial ones.

• Healthy tissues typically have low levels of senescent cells due to rapid clearance; chronic damage leads to accumulation that needs therapeutic intervention.

Promising Drug Candidates for Senolytic Therapy

• Among various candidates, navitoclax stands out as it targets BCL-2 family proteins that promote cell survival; inhibiting these can lead to selective death in senescent cells.

• Navitoclax's mechanism involves triggering apoptosis specifically in senescent cells while sparing healthy ones due to their higher reserve activity of survival proteins.

• Although navitoclax is not yet approved for general use outside cancer treatment, ongoing clinical trials are exploring its potential for age-related diseases like pulmonary fibrosis.

Additional Insights on Other Drugs

• Dasatinib is another promising drug known for its broad-spectrum tyrosine kinase inhibition; it has shown effectiveness against senescent but not non-senescent cells despite its complex action profile.

• Both navitoclax and dasatinib have been tested extensively in preclinical models (e.g., mice), showing positive results across various diseases including degenerative conditions.

• Some vulnerabilities shared between senescent and cancerous cells provide optimism regarding the repurposing of existing cancer drugs for treating age-related pathologies.

Addressing Skepticism About Drug Efficacy

Exploring Senolytics and Their Potential in Treating Inflammation

The Role of Senolytics in Disease Management

• The speaker discusses skepticism regarding the effectiveness of senolytic drugs, emphasizing the need for human trials to validate their impact on health.

• Anti-inflammatory drugs, particularly non-steroidal anti-inflammatory drugs (NSAIDs) and cortisone, are highlighted as widely prescribed medications that alleviate various diseases despite not curing them.

• The connection between senescence and inflammation is established, suggesting that if anti-inflammatories work for many conditions, senolytics could similarly benefit a range of diseases.

Experimental Evidence with Mouse Models

• An example is presented where pulmonary fibrosis is induced in mice using a genotoxic agent to study the effects of senolytic treatment.

• After 10 days post-treatment with bleomycin, significant fibrosis is observed in mice; imaging techniques like CT scans are used to assess lung function.

• Control mice show normal respiratory function while treated mice exhibit severe breathing difficulties due to fibrosis.

Treatment Outcomes and Observations

• Mice treated daily with a specific senolytic agent demonstrate improved respiratory function compared to untreated or vehicle-treated counterparts.

• Imaging reveals substantial reductions in fibrotic areas within the lungs of treated mice over time, indicating effective treatment outcomes.

Research Landscape and Future Directions

• A list from 2020 highlights various senolytic agents under investigation; ongoing research aims to identify more targeted compounds for treating specific tissues affected by senescence.

• Clinical trials are underway for conditions associated with aging; one completed trial focuses on pulmonary fibrosis using a drug called dasatinib.

Summary of Findings and Implications

• The discussion concludes by summarizing the importance of studying cellular senescence and its implications for age-related diseases.

Discussion on Senescent Cells and Aging

Targeting Senescent Cells

• The focus is on targeting senescent cells to combat aging, which involves addressing the broader issue of organismal deterioration due to a diffuse accumulation of these cells. This approach is complex and requires extensive regulatory processes and clinical trials.

Challenges in Clinical Trials

• Conducting clinical trials specifically aimed at aging rather than a concrete disease presents significant challenges. Efforts are ongoing to navigate these complexities.

Introduction of Research Team

• The speaker acknowledges their research team, particularly highlighting Fernanda Hernández, who has developed a model for human pulmonary fibrosis in mice.

Audience Engagement and Questions

• The speaker invites questions from the audience, indicating an eagerness to engage in further discussion about their laboratory's direction and findings.

Mechanical Functionality of Lungs

• A question arises regarding whether mechanical lung function is altered when introducing exogenous senescent cells. The speaker admits that this has not been measured yet but recognizes its importance for understanding the relationship between damage and mechanical defects.

Aging as Repair Mechanism Inefficacy

• The concept of aging is discussed as potentially being linked to failures in repair mechanisms rather than merely an accumulation of damage. Genetic factors influencing premature aging through DNA repair deficiencies are acknowledged.

Semantic Considerations in Defining Aging

• A question about redefining terms related to aging arises, suggesting that current terminology may provoke fear or misunderstanding. The speaker expresses a desire for alternative terminology that better encapsulates the phenomenon without negative connotations.

Onset of Cellular Senescence Detection

• Questions about when cellular senescence can be detected lead to discussions on its early presence at low levels in young individuals, with significant increases typically observed around ages 50–60 due to accumulated damage over time.

Distinction Between Types of Senescence

Cellular Senescence and Its Implications

Understanding Programmed Cell Death in Embryonic Development

• The concept of programmed cell death during embryonic development is crucial for remodeling structures that are no longer needed, similar to the role of apoptosis.

• A notable example is the embryonic liver, which is eliminated to allow for the formation of the adult liver, highlighting how temporary organs serve specific developmental purposes.

Nutritional Supplements and Their Role

• Questions arise about whether certain drugs should be taken immediately after birth; concerns focus on their potential benefits and timing.

• Nutritional supplements known as xenolytics have modest activity; examples include quercetin and fisetin, which some individuals take regularly.

• There is a movement towards conducting clinical trials outside traditional channels, where volunteers agree to take either placebo or active treatments over extended periods.

Chemotherapy's Impact on Cellular Aging

• Inquiry into whether chemotherapy or immunotherapy leads to senescent tumor cells has been a significant area of research.

• Chemotherapy can induce premature aging in survivors, with studies showing this effect in mice; termed "chemotherapy-induced frailty," it relates closely to cellular senescence.

• Researchers are exploring combining xenolytic treatments with chemotherapy to mitigate long-term side effects associated with cancer treatment.

Selectivity and Side Effects of Xenolytics

• Concerns about ensuring that xenolytic drugs target only senescent cells raise questions about potential side effects from off-target actions.

• While all drugs have side effects, initial studies in mice show no significant adverse outcomes related to cancer predisposition or complications from treating atherosclerotic plaques.

Challenges in Measuring Cellular Senescence

• The selectivity of xenolytics remains a challenge due to the lack of reliable biomarkers for measuring senescent cell burden non-invasively.

• Current methods rely heavily on invasive techniques; researchers are actively seeking non-invasive biomarkers through imaging technologies like MRI.

Autophagy's Role in Cellular Repair

• Autophagy plays a critical role in managing cellular damage within senescent cells but often fails to eliminate all accumulated damage effectively.

Discussion on Cellular Senescence and Aging

Intracellular Saturation and Autophagy

• The intracellular environment becomes saturated, leading to increased secretion from senescent cells. Activating autophagy can alleviate some of this secretion, but it has limitations.

Melatonin's Role in Cellular Senescence

• The speaker expresses limited knowledge about melatonin's effects on cellular senescence, acknowledging its positive impact on aging but uncertain studies regarding its influence on senescent cell phenotypes.

• Discussion with Professor Tresguerres highlights the need for further research into melatonin's role in cellular senescence, indicating a gap in current scientific understanding.

Challenges of Using Immortalized Cell Lines

• Carlos González raises concerns about the reliability of results from immortalized cell cultures used in laboratory studies due to potential masking of cellular processes.

• The speaker agrees that working with immortalized or cancerous cells introduces distortions, emphasizing the balance between physiological relevance and experimental manipulation.

• Despite their immortality, these cells can still activate senescence when damaged externally; however, tumor cells may become insensitive to damage sensors.

Cancer Risk and Cellular Response to Damage

• María Pilar del Río questions the relationship between cancer risk associated with aging and cellular responses like apoptosis versus senescence.

• The speaker notes that while mutations accumulate with age, chronic tissue damage creates an environment conducive to tumor growth by activating pre-existing silent tumor cells.

• Emphasizes that merely having mutated cells is insufficient for tumor development; external tissue damage is necessary for creating a supportive microenvironment for tumors.

Role of Senescent Cells in Tumor Growth

• Senescent cells contribute significantly to creating a microenvironment that promotes tumor growth through their secretory profile.

• Evidence suggests that genetically induced senescent bone marrow enhances metastasis compared to non-senescent counterparts due to cytokine production favorable for tumor survival.

Longevity and Cellular Senescence

• A question arises regarding whether less long-lived species exhibit greater levels of cellular senescence compared to longer-lived ones.

• The speaker indicates that more long-lived species tend to have more effective DNA repair systems, which correlates with lower accumulated damage over time.

Discussion and Acknowledgments

Acknowledgment of Contributions

• The speaker expresses gratitude towards Manuel Serrano, encouraging him to share his contact information for further communication.

• Appreciation is extended to the team at Fundación General UCM for their technical support during the event, highlighting their behind-the-scenes efforts.

• The speaker acknowledges the significant reputation of Manuel Serrano and thanks him on behalf of the faculty for dedicating time to the discussion.